Phase I Trial Combining Temozolomide plus Lapatinib for the Treatment of Brain Metastases in Patients with Her2-Positive Metastatic Breast Cancer: the Laptem Trial
AuthID
P-006-JE0
P-006-JE0
© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service